Furthermore, upregulated AFAP1-AS1 expression enhanced the gemcitabine tolerance whereas suppressed AFAP1-AS1 attenuated the gemcitabine tolerance, which was comparable to the study on AFAP1-AS1 in esophageal squamous cell cancer [28]. Here, AFAP1 is linked to esophageal squamous cell carcinoma.